Sysmex (OTCMKTS:SSMXY) Shares Gap Up – What’s Next?

Sysmex Corporation ADR (OTCMKTS:SSMXY)’s stock price gapped up prior to trading on Friday . The stock had previously closed at $9.15, but opened at $9.60. Sysmex shares last traded at $9.8050, with a volume of 57,070 shares changing hands.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the company. Zacks Research upgraded Sysmex from a “strong sell” rating to a “hold” rating in a research report on Thursday, August 14th. The Goldman Sachs Group raised shares of Sysmex from a “hold” rating to a “buy” rating in a research note on Thursday, October 9th. One investment analyst has rated the stock with a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy”.

Sysmex Price Performance

The stock has a market capitalization of $6.17 billion, a PE ratio of 19.60 and a beta of 1.16. The company has a debt-to-equity ratio of 0.12, a current ratio of 3.37 and a quick ratio of 2.49. The firm’s 50 day simple moving average is $11.63 and its 200 day simple moving average is $14.43.

Sysmex (OTCMKTS:SSMXY) last posted its quarterly earnings results on Wednesday, November 5th. The company reported $0.16 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.16. Sysmex had a net margin of 9.35% and a return on equity of 10.20%. The business had revenue of $826.60 million during the quarter, compared to analyst estimates of $880.80 million. As a group, equities analysts forecast that Sysmex Corporation ADR will post 0.57 EPS for the current fiscal year.

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.